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Abstract
In a rigorous systematic review, Dukhanin and colleagues categorize metrics and evaluative tools of the 
engagement of patient, public, consumer, and community in decision-making in healthcare institutions and 
systems.  The review itself is ably done and the categorizations lead to a useful understanding of the necessary 
elements of engagement, and a suite of measures  relevant to implementing engagement in systems. Nevertheless, 
the question remains whether the engagement of patient representatives in institutional or systemic deliberations 
will lead to improved clinical outcomes or increased engagement of individual patients themselves in care. 
Attention to the conceptual foundations of patient engagement would help make this systematic review relevant 
to the clinical care of patients. 
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While patient engagement is often mentioned as an important goal for healthcare organizations, how is it to be defined and measured, and what 
is its relevance for clinical care? In this rigorous and detailed 
systematic review by Dukhanin et al,1 the authors come to 
informative, helpful conclusions about the very nature of 
patient engagement and patient engagement metrics, even 
granting the limitations of their dataset and systematic 
reviews in general.
The first question concerns the meaning of engagement, 
or, rather, “patient, public, consumer and community 
(P2C2) engagement in organization-, community-, and 
system-level healthcare decision-making.” For the purposes 
of this review, the authors defined P2C2 engagement as 
“a continuous systematic effort to incorporate the needs, 
values, and preferences of the P2C2 engagement participants 
into decision-making.” That is to say, engagement involves 
participants as representatives of their communities or 
constituencies rather than focusing on the engagement of 
individuals in decision-making themselves. While the authors 
of any systematic review are free to define their topic as they 
wish for reasons of feasibility and clarity, the reader may fairly 
ask whether their definition serves a clinical purpose. Is it the 
case that including representatives of patient groups will lead 
to engagement of patients as individuals, or restructuring of 
healthcare systems to take patient concerns into account? 
We will consider the potential clinical relevance of this 
review in our conclusion, but one alternative way to consider 
the conceptual framework of patient engagement at multiple 
levels, rather than solely the organization-, community- and 
systems-level, is as a multicomponent intervention, including 
other additional dimensions. On the one hand, social and 
political axes of engagement might enable greater exercise of 
power by community organizations and individual patients; 
and by redistributing resources to economically disadvantaged 
patients. Individual axes of engagement might involve the use 
of shared decision-making.2
What studies were considered in this review? The authors 
included studies from all countries, not just the United States, 
and studies from 1962 onward. In so doing, the authors 
recognized that patient engagement is not an innovation of late 
vintage, but the subject of repeated attempts and initiatives on 
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the part of healthcare organizations and systems for decades. 
(Perhaps the fact that patient engagement has been a long-
standing topic of research indicates the difficulties associated 
with effective implementation.)
Most full-text articles included in this current review 
identified tools implemented in the United States (12 of 23 
tools), 3 in Canada, 3 in the United Kingdom, 2 in Nepal; the 
rest described tools implemented in assorted low- or middle-
income (Djibouti, Honduras, South Africa, or Tanzania) or 
high-income countries (Ireland or New Zealand).
How was patient engagement assessed in the included 
studies? The authors first categorized included articles 
depending on whether they addressed outcome or process. 
Much as diabetes affects both measures of blood sugar and 
the clinical outcomes of interest, patient engagement can be 
assessed via the processes which reflect such engagement 
or the outcomes which are the result of such engagement. 
Process and outcome were further categorized by subdomain 
and metric within that subdomain; we consider these below.
Outcome domains were subcategorized into internal 
outcomes (relevant to and evaluated within a healthcare 
organization or system), external outcomes (eg, relating to 
population health or influence on the broader public) or 
cost-effectiveness, further categorized into “internal” and 
“external” aspects. 
Process metrics were categorized into four subdomains: 
direct process metrics (evaluating the degree of direct control 
P2C2 have over the decision-making process); surrogate 
process metrics (which measure formal elements of the 
decision-making processes, not direct control, eg, whether 
patients have veto power); preconditions for engagement 
metrics (eg, characteristics which make it possible for there to 
be patient participation – for example, parking arrangements 
or compensation for participation); and, finally, aggregate 
process metrics, which assess various domains of the process 
and are meant to provide summary measures.
Thus, the included studies comprise a suite of measurement 
tools and metrics suitable for use in healthcare organizations. 
In addition, the organization of metrics according to the 
Arstein language of engagement will help practitioners 
prioritize different management strategies. 
Two other findings are worth highlighting. First, some 
relevant domains are underemphasized or not addressed by the 
literature on patient engagement metrics. For example, only 
two tools measured improved trust in the organization, and 
no tool measured either sustainability of engagement or the 
capacity to increase or scale engagement. P2C2 participants’ 
involvement in finalizing decisions was evaluated in only one 
metric. 
The authors limited their review to organization and system 
level decisions in which P2C2 could engage, as they say, “[Such 
domains] were excluded to focus our review, and because 
existing engagement frameworks consider engagement in 
organization-, community-, and system-level decisions as 
a conceptually distinct activity from engagement in more 
societal-level decisions.” The obvious question is whether a 
different scope of this research question might have led to 
different methods for assessing patient engagement. If patient 
advocacy were associated with greater influence in the design 
of national health systems, eg, in prioritizing biomedical 
approaches vs. social determinants of health, would that effect 
greater patient engagement? The fact that this would require a 
differently scoped systematic review does not mean that such 
a broader look is not potentially relevant. 
To revisit our initial question, does engagement of P2C2 
within a given healthcare organization achieve patient-
important or clinically relevant outcomes (not to mention 
public health or population outcomes, which this review 
explicitly does not consider)? In other words, where should 
engagement take place, and where should patient (or 
consumer or public) influence act in order to be truly felt in 
healthcare? Perhaps disaggregating the P2C2 group would 
lead to answers in this regard. 
Lastly, it is possible that some kinds of patient engagement 
were not captured in this review. A recent (2018) scoping review 
by Scholl et al3 considers institutional and organizational 
characteristics that influence the implementation of 
interventions to encourage shared decision-making in 
healthcare settings; one can argue that SDM is itself a means 
to patient engagement. The review addressed not metrics (as 
in this work) but characteristics of systems; thus perhaps the 
two bodies of evidence can be combined to provide a road 
map for engagement with patients in decision-making on 
an organizational level. This would also require a broadened 
understanding of SDM, which has generally been taken to 
apply to the individual encounter between doctor and patient. 
Whether SDM at the systems level means merely encouraging 
SDM at the patient-provider level, or if – in addition – this 
implies sharing of systems-level decisions with patients, is a 
question that does not yet have a clear answer. 
Equipped with this review and detailed understanding of 
how exactly researchers, clinicians, and patients can go about 
measuring patient engagement, we can take further steps to 
actually improving its implementation in the world.
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